Week In Review: MassRoots’ Woes, GW Pharma’s Good News & Pro-Legalization Polls

By Omar Sacirbey and John Schroyer

MassRoots lands in financial hot water, GW Pharmaceuticals takes a step closer to winning U.S. approval for its marijuana-based drug, and a political veteran urges caution heading into the elections.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

MassRoots in Hot Water?

That’s the assessment of Nic Easley, the CEO of Denver’s 3C Consulting. He looked closely at the company’s situation following news that the cannabis-themed social network failed to…